Savill Corrine (CIK 0001837524)

Latest company ownership

CGEM - Cullinan Therapeutics, Inc.

Role: Chief Business Officer

Shares held

75,000

Last filed at

Feb 21, 2025

Confidence Score

50.0

2025Q4

Confidence Score History

2022Q3 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Feb 1, 2024	Feb 2, 2024	Cullinan Therapeutics, Inc.	Chief Business Officer	Sell	17.5	-40,000	-19.42%	✓	$647.2K
Jan 29, 2024	Jan 30, 2024	Cullinan Therapeutics, Inc.	Chief Business Officer	Sell	17.5	-40,000	-19.42%	✓	$563.6K
Jan 22, 2024	Jan 24, 2024	Cullinan Therapeutics, Inc.	Chief Business Officer	Sell	30.0	-40,000	-7.38%	✓	$492.5K
Jul 18, 2022	Jul 21, 2022	Cullinan Therapeutics, Inc.	Acting Chief Business Officer	Sell	22.5	-20,000	-11.79%	✓	$303.6K
Jul 11, 2022	Jul 12, 2022	Cullinan Therapeutics, Inc.	Acting Chief Business Officer	Sell	17.5	-40,000	-19.08%	✓	$533.3K